NO LimitsThalidomideStory.com

is a film about Thalidomide, a drug made by Grünenthal which severely disabled thousands of babies in the 60's and caused the worst pharmaceutical scandal in history.
"NO Limits" A film by John Zaritsky now on Amazon Prime
  • THALIDOMIDER STORIES
  • ABOUT THE DRUG THALIDOMIDE
  • ABOUT GRÜNENTHAL
  • OTHER NOTABLES
  • TIMELINE
  • FILM
  • RESOURCES
  • THALIDOMIDER STORIES
    • Thalidomiders
      • Alvin Law
        • Rejected at birth
        • My life became this life
        • Why do I need arms?
        • I love driving!
        • Building character
        • This is how I do things
        • Motivational Speaker
        • Alvin Law Bio
      • Eileen Cronin
        • Four Leaf Clover
        • Love at first sight
        • Artificial Limbs
        • Eileen Cronin Bio
      • Niko von Glasow
        • A timid child
        • Becoming a director
        • Time to look the devil in the asshole
        • Nobody's Perfect
        • The most important thing
        • It's good to be rich!
        • Niko von Glasow Bio
      • Louise Mason
        • Growing Up
        • Bullying
        • Marriage
        • Louise Mason Bio
      • Jan Schulte-Hillen
        • Just forget about him
        • We had a lot of fun
        • Son, do your own thing.
        • Jan Schulte-Hillen Bio
      • Lynette Rowe
        • A deadly silence
        • Caring for Lynnette
        • A class action law suit
        • Lynette Rowe Bio
      • Paul Murphy
        • Doctors pressured to use Thalidomide
        • A breach birth
        • Bring that baby home!
        • Troubled teenage years
        • There's always a solution
        • Paul Murphy Bio
      • Monika Eisenberg
        • I had to fight to survive
        • My mother and me
        • Hadamar - a dark shadow
        • No Boundaries
        • Monika Eisenberg and "minor guilt"
        • Remembering the victims
        • Monika Eisenberg Bio
  • ABOUT THE DRUG THALIDOMIDE
    • Why Thalidomide?
      • It was supposed to be Safe
      • Grünenthal Sales Motto "Succeed at any cost"
      • Their apology came from their lawyers
    • Distribution & Marketing
      • Canada
      • Australia and New Zealand
      • Austria
      • Brazil
      • Germany
      • United Kingdom
      • Italy
      • Ireland
      • Japan
      • Spain
      • Sweden
      • United States
    • Current Uses
      • A new treatment for leprosy
      • Thalidomide and Leprosy
      • A huge Thalidomide comeback
      • Celgene and Thalidomide
      • Thalidomide a big money maker
    • Reaction To The Crisis
      • "Wonder drug" or baby killer?
      • Reminiscent of the Nazi era
      • Thalidomide babies killed
      • Better drug safety laws implemented
      • Germany
      • Germany - "A Single Pill"
      • Canada
      • United Kingdom
      • USA
      • Australia
      • A Cautionary Tale
  • ABOUT GRÜNENTHAL
    • Company History
      • From Soap to Thalidomide
      • Ex-Nazis find a home at Grünenthal
      • Sales at all Costs
      • Minor Guilt for a Major Catastrophe
      • Contergan exposed by Morley Safer
    • 1968 German Trial
      • Grünenthal's founder evades trial
      • 1960's German justice-a banana republic?
      • 1968 German trial tactics
      • Grünenthal claims "minor guilt"
      • Unveiling the German trial documents
    • 2012 Apology
      • Grünenthal finally apologizes
      • Grünenthal's 2012 Apology
      • Reactions to Grünenthal apology
      • Apology comes from the heart
      • A bronze statue
      • A visit to the statue
  • OTHER NOTABLES
    • Historical Figures
      • Frances Kelsey
      • William McBride
      • Widukind Lenz
      • Carl-Hermann
      • Hermann Wirtz, SR
      • Heinrich Mückter
      • Otto Ambros
    • Others
      • Michael Magazanik
      • Martin Johnson
      • Peter Gordon
      • Linde Schulte-Hillen
      • Sir Harold Evans
  • TIMELINE
    • TIMELINE
      • 1939: Scientists discover that a drug can pass through the placenta and damage a fetus
      • 1946: Chemie Grünenthal GmbH is founded
      • 1947: Grünenthal mainly manufactures antibiotics
      • Winter, 1954: Keller and Kunz synthesize new compound later to be called Thalidomide
      • April, 1954: Grünenthal obtains a 20 year patent for K 17
      • 1955: Thalidomide or K17 is tested on animals
      • 1955: Thalidomide or K 17 is tested on humans
      • June, 1955: K 17 “is ready to go on the market”
      • October 21, 1955: An expert recommends that tests should be done over a period of at least 9 to 12 months
      • December 15, 1955: Thalidomide is a substance without “undesirable side effects”
      • March, 1956: Dr. Piacenza writes about “light paresthesia” (“pins and needles”) in connection with K 17
      • July 10, 1956: The NRW Department of Health approves the sale drugs containing of Thalidomide
      • August, 1956: Paper on thalidomide talks about its “sedative effect” and its “extreme non-toxicity”
      • December 25, 1956: The first known Thalidomide baby is born
      • July 5, 1957: Grünenthal asks Bonn University prof to include K 17 in pregnant women test
      • September 2, 1957: Thalidomide gets the name “Contergan” for the German market
      • September 26, 1957: Ads about Contergan are to focus on its sensational “absolute non-­toxicity” and “safeness”
      • October 1, 1957: Contergan is put on the West-German market
      • December, 1957: “Unrest and states of excitements” cease to be mentioned
      • 1958: Contergan is highly advertised
      • 1958: Thalidomide sample pills distributed in the US
      • March 3, 1958: Doctors complain about the wording “absolute non-toxic”
      • April, 1958: Thalidomide sold in Great Britain under the trade-name Distaval
      • August 1, 1958: Grünenthal uses unrelated test results to promote the safety of Thalidomide for pregnant women
      • August 26, 1958: Report on difficulties in walking
      • 1959: Growing critical voices
      • 1959: Thalidomide under brand names is available as samples in Canada
      • January, 1959: Thalidomide is advertised in a journal about obstetrics and gynecology
      • January, 1959: 1959 - USA
      • March, 1959: Complaints about cold feet and hands
      • June 23, 1959: 1959 - Canada
      • July 14, 1959: A consumer believes his paresthesia is connected to Contergan
      • August, 1959: More cases of polyneuritis
      • August 17, 1959: Grünenthal doesn’t take growing number of complaints seriously
      • October 3, 1959: Dr. Voss alerts Grünenthal about nerve damage
      • October 15, 1959: Sievers and Werner are lying again
      • November 27, 1959: Voss informs Grünenthal about more cases of polyneuritis and clearly warns about a possible toxicity
      • November 27, 1959: More warnings on that same day
      • December 30, 1959: Dr. Werner and Dr. Sievers lie again
      • January 14, 1960: Contergan is “devil’s work”
      • February 23, 1960: “Contergan causes damage”, according to a neurologist
      • March 1, 1960: Contergan is the most-sold sedative in Germany
      • March 8, 1960: Once again Grünenthal denies having heard of cases of polyneuritis.
      • April, 1960: A Grünenthal representative starts visiting the Ministry of Interior in NRW
      • April, 1960: Grünenthal visits Voss trying to influence him
      • April 14, 1960: Dr. Mückter says “everything needs to be done to prevent the prescription requirement”
      • May 1, 1960: Neurologist Voss publicly talks about nerve damage
      • Summer, 1960: June to October 1960
      • August 10, 1960: Linde Schulte-Hillen takes one pill of Contergan
      • September 8, 1960: 1960 Canada
      • September 12, 1960: 1960 USA
      • Fall, 1960: Defendants assume the “likeliness” of the nerve damaging effects of Contergan
      • October, 1960: Some hospitals stop giving out Thalidomide
      • November, 1960: The net sales revenue for Contergan reaches 1,215,600 Marks
      • November, 1960: A note that warns about nerve damage is included in the instruction leaflet
      • November 17, 1960: “For Contergan we fight to the last breath.”
      • November 22, 1960: Notice of compliance from the Canadian Food and Drug Directorate
      • November 24, 1960: Pharmacist inquires about malformations
      • December, 1960: "Everything is done to protect our ‘eyeball’"
      • December 31, 1960: First publication about Thalidomide and nerve damage
      • 1961: McBride informs Distillers about three malformed babies born in his care
      • January, 1961: Contergan sales in Germany reach their highest point
      • January, 1961: Certainty that Contergan is responsible for nerve damage
      • January 16, 1961: Negative articles about Contergan "are to be prevented"
      • January 17, 1961: Grünenthal suppresses knowledge of reports about damaged babies and children
      • February 15, 1961: Voss thinks nerve damage is irreversible
      • February 27, 1961: Dr. Sievers and Dr. Werner say Contergan doesn’t cause damage
      • March, 1961: Kelsey reads Florence’s letter in the British Medical Journal
      • April 1, 1961: Thalidomide enters Canadian market
      • April 21, 1961: A Grünenthal sales rep makes fun of patients at psychiatric ward who do not notice their nerve damage
      • May, 1961: Dr. Frenkel and others publish articles about nerve damage caused by Contergan
      • May 11, 1961: Kelsey asks if Thalidomide can harm a fetus
      • May 26, 1961: Grünenthal revises package leaflet for Thalidomide
      • June, 1961: Lenz and Schulte-Hillen collect evidence in Northern Germany
      • June 26, 1961: Prescription requirement for Thalidomide containing preparations recommended
      • June 27, 1961: Randolph Reginald Warren is born
      • Summer, 1961: Grünenthal wonders if Thalidomide can pass the placenta
      • August 1, 1961: Prescription requirement is introduced, but only in three federal states
      • August 16, 1961: Grünenthal pays compensation to patients with nerve damage
      • September, 1961: The first article about the increasing numbers of malformed babies is published
      • September 26, 1961: FDA wants pregnancy warning included in instruction leaflet
      • October, 1961: Grünenthal informed about a malformation on a newborn possibly connected to Thalidomide
      • October, 1961: Contergan likely responsible for the malformations
      • October 3, 1961: Thalidomide disturbs bone growth in chickens
      • November 15, 1961: Lenz phones Grünenthal, demanding Thalidomide be taken off the market immediately
      • November 17, 1961: Dr. Lenz sends summary of his observations to Grünenthal
      • November 19, 1961: Lenz publicly talks about his suspicion
      • November 20, 1961: Grünenthal executives meet with Lenz in Hamburg
      • November 20, 1961: Grünenthal sends out 66,957 letters to doctors saying their drug was safe.
      • November 24, 1961: Grünenthal is informed about McBride’s warnings in Australia
      • November 25, 1961: The Ministry of the Interior informs several offices in Germany about the new suspicion against Thalidomide
      • November 26, 1961: The newspaper article that finally makes Grünenthal act is published
      • November 27, 1961: Withdrawal of Thalidomide from the West German market
      • November 30, 1961: Experts believe Thalidomide is responsible for malformations
      • December, 1961: By end of 1961, 1800 cases of nerve damage reported to Grünenthal
      • December 1, 1961: Criminal charges against Grünenthal are filed in Hanover
      • December 2, 1961: Distillers takes Thalidomide off the market in the UK and Australia
      • December 5, 1961: Thalidomide stays on the Canadian market for another four months
      • December 16, 1961: The prosecution in Aachen starts its criminal investigation proceedings
      • 1962: Scientists demonstrate teratogenicity
      • February, 1962: Times Magazine reports Thalidomide still available in Canada
      • March 2, 1962: Thalidomide removed from the market in Canada
      • May, 1962: UK government warning issued
      • July 4, 1962: Grünenthal still denies any connection between Thalidomide and malformations
      • August 7, 1962: Kelsey presented award by JFK
      • August 9, 1962: Thalidomide Society is formed by parents in Britain
      • October 10, 1962: USA - Drug Amendments Act is passed
      • March 16, 1963: The Federal Association of Thalidomide Victims is founded
      • 1964: Thalidomide can be useful in treating leprosy patients
      • December, 1966: Josef Neuberger is appointed Minister of Justice in NRW
      • March 13, 1967: Aachen prosecutors file a suit against Grünenthal
      • 1968: Distillers offers modest settlement amounts to survivors in the UK
      • May 27, 1968: The trial begins in Alsdorf
      • August 12, 1968: Lenz testifies at the trial
      • July, 1969: Government interference in the German Thalidomide trial
      • October 10, 1969: Courts decides that Lenz’ testimony cannot be used
      • January 26, 1970: Grünenthal agrees to pay 100 Million Marks
      • April 10, 1970: A settlement is reached
      • December 18, 1970: The trial in Alsdorf ends without a verdict
      • March, 1971: Richardson-Merrel is sued in the US
      • September 24, 1972: UK Media campaigns
      • October 31, 1972: Disabled Children's Relief Foundation for People with Disabilities set up
      • 1973: Settlement package by Distillers
      • August 10, 1973: UK Thalidomide Children’s Trust established
      • April, 1974: The patent protection expires
      • January 1, 1978: The new German Drug Law comes into effect
      • December, 1987: Thalidomide Victims Association of Canada is formed
      • 1991: Canada-$21 million assistance package
      • 1993: UK-actuarial report
      • June, 1993: Reports on deformities in Brazil
      • December, 1996: USA - Celgene askes the FDA for permission to distribute Thalidomide
      • 1997: Compensation Grünenthal committed to in 1971 is used up
      • 1998: USA - FDA approves use to treat ENL
      • November, 2002: UK - Fight for a better deal for Thalidomiders
      • 2004: Application for Thalidomide to enter the European market
      • July, 2004: UK - Campaign to stop taxation on Thalidomide compensation
      • 2005: UK - Improved deal is reached with Diageo
      • August 19, 2005: The “Contergan Foundation” is renamed
      • 2006: Schulte-Hillen and Grünenthal try to prevent the broadcast of a TV movie about the Contergan scandal
      • 2006: USA - FDA approves Thalomid for treatment of multiple myeloma
      • 2007: Improved survival rates of bone-marrow cancer patients
      • November 7, 2007: The WDR broadcasts the movie “Eine Einzige Tablette”
      • December, 2007: First meeting - Grünenthal and the German Federal Association of Thalidomide Victims
      • 2008: EU approval for treatment of multiple myeloma
      • May, 2008: Grünenthal announces 50 Million Euros payment
      • 2009: UK - 20 million pound grant
      • June 29, 2009: The second amendment to the “Contergan Foundation Law” comes into effect
      • 2010: UK - formal apology to Thalidomide victims
      • July, 2010: 50 million Australian dollars paid to survivors
      • June, 2011: Grünenthal offers to reimburse “extraordinary” costs
      • June, 2011: Australia - Peter Gordon launches landmark international class action suit
      • October, 2011: First hearing of class action suit - Australia
      • December, 2011: Australian victims win right to have class action
      • July 19, 2012: Thalidomide settlement for Lynette Rowe
      • August 31, 2012: Grünenthal offers an apology
      • 2012: Grünenthal's 2012 Apology
      • December, 2012: Grünenthal establishes company-owned foundation
      • December, 2012: UK survivors to receive 80 million pounds
      • April, 2013: The German Bundestag significantly raises the monthly benefits
      • December, 2013: Australia and New Zealand award
      • December, 2014: Canada - motion 'to right the wrong'
      • March 6, 2015: Canadian government announces compensation package
    • Compensation
      • August 16, 1961: Grünenthal pays compensation to patients with nerve damage
      • November 30, 1961: Experts believe Thalidomide is responsible for malformations
      • December 1, 1961: Criminal charges against Grünenthal are filed in Hanover
      • December 16, 1961: The prosecution in Aachen starts its criminal investigation proceedings
      • July 4, 1962: Grünenthal still denies any connection between Thalidomide and malformations
      • August 9, 1962: Thalidomide Society is formed by parents in Britain
      • March 16, 1963: The Federal Association of Thalidomide Victims is founded
      • December, 1966: Josef Neuberger is appointed Minister of Justice in NRW
      • March 13, 1967: Aachen prosecutors file a suit against Grünenthal
      • 1968: Distillers offers modest settlement amounts to survivors in the UK
      • May 27, 1968: The trial begins in Alsdorf
      • August 12, 1968: Lenz testifies at the trial
      • July, 1969: Government interference in the German Thalidomide trial
      • October 10, 1969: Courts decides that Lenz’ testimony cannot be used
      • January 26, 1970: Grünenthal agrees to pay 100 Million Marks
      • April 10, 1970: A settlement is reached
      • December 18, 1970: The trial in Alsdorf ends without a verdict
      • March, 1971: Richardson-Merrel is sued in the US
      • September 24, 1972: UK Media campaigns
      • October 31, 1972: Disabled Children's Relief Foundation for People with Disabilities set up
      • 1973: Settlement package by Distillers
      • August 10, 1973: UK Thalidomide Children’s Trust established
      • December, 1987: Thalidomide Victims Association of Canada is formed
      • 1991: Canada-$21 million assistance package
      • 1993: UK-actuarial report
      • 1997: Compensation Grünenthal committed to in 1971 is used up
      • November, 2002: UK - Fight for a better deal for Thalidomiders
      • July, 2004: UK - Campaign to stop taxation on Thalidomide compensation
      • 2005: UK - Improved deal is reached with Diageo
      • May, 2008: Grünenthal announces 50 Million Euros payment
      • 2009: UK - 20 million pound grant
      • June 29, 2009: The second amendment to the “Contergan Foundation Law” comes into effect
      • July, 2010: 50 million Australian dollars paid to survivors
      • June, 2011: Grünenthal offers to reimburse “extraordinary” costs
      • June, 2011: Australia - Peter Gordon launches landmark international class action suit
      • October, 2011: First hearing of class action suit - Australia
      • December, 2011: Australian victims win right to have class action
      • July 19, 2012: Thalidomide settlement for Lynette Rowe
      • December, 2012: Grünenthal establishes company-owned foundation
      • December, 2012: UK survivors to receive 80 million pounds
      • April, 2013: The German Bundestag significantly raises the monthly benefits
      • December, 2013: Australia and New Zealand award
      • December, 2014: Canada - motion 'to right the wrong'
      • March 6, 2015: Canadian government announces compensation package
    • Distribution
      • October 1, 1957: Contergan is put on the West-German market
      • 1958: Thalidomide sample pills distributed in the US
      • April, 1958: Thalidomide sold in Great Britain under the trade-name Distaval
      • 1959: Thalidomide under brand names is available as samples in Canada
      • January, 1959: Thalidomide is advertised in a journal about obstetrics and gynecology
      • January, 1959: 1959 - USA
      • June 23, 1959: 1959 - Canada
      • March 1, 1960: Contergan is the most-sold sedative in Germany
      • September 8, 1960: 1960 Canada
      • November, 1960: The net sales revenue for Contergan reaches 1,215,600 Marks
      • November 17, 1960: “For Contergan we fight to the last breath.”
      • November 22, 1960: Notice of compliance from the Canadian Food and Drug Directorate
      • December, 1960: "Everything is done to protect our ‘eyeball’"
      • January, 1961: Contergan sales in Germany reach their highest point
      • March, 1961: Kelsey reads Florence’s letter in the British Medical Journal
      • April 1, 1961: Thalidomide enters Canadian market
      • May 26, 1961: Grünenthal revises package leaflet for Thalidomide
      • August 1, 1961: Prescription requirement is introduced, but only in three federal states
      • September 26, 1961: FDA wants pregnancy warning included in instruction leaflet
      • November 26, 1961: The newspaper article that finally makes Grünenthal act is published
      • December 2, 1961: Distillers takes Thalidomide off the market in the UK and Australia
      • December 5, 1961: Thalidomide stays on the Canadian market for another four months
      • February, 1962: Times Magazine reports Thalidomide still available in Canada
      • March 2, 1962: Thalidomide removed from the market in Canada
      • May, 1962: UK government warning issued
      • 1964: Thalidomide can be useful in treating leprosy patients
      • January 1, 1978: The new German Drug Law comes into effect
      • June, 1993: Reports on deformities in Brazil
      • December, 1996: USA - Celgene askes the FDA for permission to distribute Thalidomide
      • 1998: USA - FDA approves use to treat ENL
      • 2004: Application for Thalidomide to enter the European market
      • 2006: USA - FDA approves Thalomid for treatment of multiple myeloma
      • 2007: Improved survival rates of bone-marrow cancer patients
      • 2008: EU approval for treatment of multiple myeloma
    • Early Warnings
      • 1955: Thalidomide or K 17 is tested on humans
      • June, 1955: K 17 “is ready to go on the market”
      • October 21, 1955: An expert recommends that tests should be done over a period of at least 9 to 12 months
      • December, 1957: “Unrest and states of excitements” cease to be mentioned
      • August 26, 1958: Report on difficulties in walking
      • 1959: Growing critical voices
      • March, 1959: Complaints about cold feet and hands
      • July 14, 1959: A consumer believes his paresthesia is connected to Contergan
      • August, 1959: More cases of polyneuritis
      • August 17, 1959: Grünenthal doesn’t take growing number of complaints seriously
      • October 3, 1959: Dr. Voss alerts Grünenthal about nerve damage
      • October 15, 1959: Sievers and Werner are lying again
      • November 27, 1959: Voss informs Grünenthal about more cases of polyneuritis and clearly warns about a possible toxicity
      • November 27, 1959: More warnings on that same day
      • December 30, 1959: Dr. Werner and Dr. Sievers lie again
      • January 14, 1960: Contergan is “devil’s work”
      • February 23, 1960: “Contergan causes damage”, according to a neurologist
      • March 8, 1960: Once again Grünenthal denies having heard of cases of polyneuritis.
      • April, 1960: A Grünenthal representative starts visiting the Ministry of Interior in NRW
      • April, 1960: Grünenthal visits Voss trying to influence him
      • April 14, 1960: Dr. Mückter says “everything needs to be done to prevent the prescription requirement”
      • May 1, 1960: Neurologist Voss publicly talks about nerve damage
      • Summer, 1960: June to October 1960
      • September 12, 1960: 1960 USA
      • Fall, 1960: Defendants assume the “likeliness” of the nerve damaging effects of Contergan
      • October, 1960: Some hospitals stop giving out Thalidomide
      • November 17, 1960: “For Contergan we fight to the last breath.”
      • November 24, 1960: Pharmacist inquires about malformations
      • December 31, 1960: First publication about Thalidomide and nerve damage
      • 1961: McBride informs Distillers about three malformed babies born in his care
      • January, 1961: Certainty that Contergan is responsible for nerve damage
      • January 16, 1961: Negative articles about Contergan "are to be prevented"
      • January 17, 1961: Grünenthal suppresses knowledge of reports about damaged babies and children
      • February 15, 1961: Voss thinks nerve damage is irreversible
      • February 27, 1961: Dr. Sievers and Dr. Werner say Contergan doesn’t cause damage
      • March, 1961: Kelsey reads Florence’s letter in the British Medical Journal
      • April 21, 1961: A Grünenthal sales rep makes fun of patients at psychiatric ward who do not notice their nerve damage
      • May, 1961: Dr. Frenkel and others publish articles about nerve damage caused by Contergan
      • May 11, 1961: Kelsey asks if Thalidomide can harm a fetus
      • June, 1961: Lenz and Schulte-Hillen collect evidence in Northern Germany
      • Summer, 1961: Grünenthal wonders if Thalidomide can pass the placenta
      • September, 1961: The first article about the increasing numbers of malformed babies is published
      • September 26, 1961: FDA wants pregnancy warning included in instruction leaflet
      • October, 1961: Grünenthal informed about a malformation on a newborn possibly connected to Thalidomide
      • October, 1961: Contergan likely responsible for the malformations
      • October 3, 1961: Thalidomide disturbs bone growth in chickens
      • November 15, 1961: Lenz phones Grünenthal, demanding Thalidomide be taken off the market immediately
      • November 17, 1961: Dr. Lenz sends summary of his observations to Grünenthal
      • November 19, 1961: Lenz publicly talks about his suspicion
      • November 20, 1961: Grünenthal executives meet with Lenz in Hamburg
      • November 20, 1961: Grünenthal sends out 66,957 letters to doctors saying their drug was safe.
      • November 24, 1961: Grünenthal is informed about McBride’s warnings in Australia
      • November 25, 1961: The Ministry of the Interior informs several offices in Germany about the new suspicion against Thalidomide
      • November 26, 1961: The newspaper article that finally makes Grünenthal act is published
      • November 27, 1961: Withdrawal of Thalidomide from the West German market
    • Thalidomiders
      • July 22, 1960: Alvin Law is born
      • August 23, 1960: Niko von Glasow is born
      • September 26, 1960: Eileen Cronin is born
      • April 25, 1961: Jan Schulte-Hillen is born
      • February 27, 1962: Moni Eisenberg is born
      • March 2, 1962: Lynette Rowe is born
      • March 26, 1962: Paul Murphy born
      • June 23, 1962: Louise Mason is born
  • FILM
    • Screenings
    • Trailer
    • About
    • Team
      • John Zaritsky
      • Anne Pick
      • Bill Spahic
    • Film Credits
    • Press
  • RESOURCES
It was the worst drug disaster in history.
A “wonder drug” sedative called Thalidomide was mass distributed around the world by the German company Chemie Grünenthal : aggressively marketed as totally non-toxic and claiming to be completely harmless for pregnant mothers experiencing morning sickness. In reality it killed and malformed thousands of babies. Many of them had short arms or legs, or no arms or legs at all. Many were blind or deaf, or had severe damage to their brains or organs.

3-Home-Slides-Thalidomide4-Home-Slides-Thalidomide1-Home-Slides-Thalidomide9-Home-Slides-Thalidomide2-Home-Slides-Thalidomide5-Home-Slides-Thalidomide6-Home-Slides-Thalidomide7-Home-Slides-Thalidomide8-Home-Slides-Thalidomide Now, almost 60 years after the drug was unleashed on an unsuspecting public, a class action lawsuit in Australia finally unveils the hidden truth.
The feature documentary ‘NO LIMITS’ follows the tragic story through the remarkable life affirming journeys of survivors around the world, as they grow from children to adults, determined to succeed, still waiting for adequate support and compensation from their governments, the drug’s distributors and the drug’s manufacturer, Grünenthal.

 THALIDOMIDER STORIES >
docchannel © Copyright 2016 R2RKB.Inc. | All Rights Reserved
  • Terms of Use
  • Website Credits
  • Contact